Evidence map›Paper›PMID 25551456›Full record

ArticlePloS one2014

Subfamily-specific adaptations in the structures of two penicillin-binding proteins from Mycobacterium tuberculosis.

Daniil M Prigozhin, Inna V Krieger, John P Huizar, Daniela Mavrici, Geoffrey S Waldo, Li-Wei Hung, James C Sacchettini, Thomas C Terwilliger, Tom Alber

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Crystal Structure of Phosphoserine BlaC fromInternational journal of molecular sciences · 2019
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Daniil M PrigozhinDepartment of Molecular and Cell Biology and California Institute for Quantitative Biosciences, University of California, Berkeley, California, 94720, United States of America.
Inna V KriegerLos Alamos National Laboratory, Los Alamos, New Mexico, 87545, United States of America; Department of Biochemistry and Biophysics, Texas A & M University, College Station, Texas, 77843, United States of America.
John P HuizarDepartment of Molecular and Cell Biology and California Institute for Quantitative Biosciences, University of California, Berkeley, California, 94720, United States of America.
Daniela MavriciDepartment of Molecular and Cell Biology and California Institute for Quantitative Biosciences, University of California, Berkeley, California, 94720, United States of America.
Geoffrey S WaldoLos Alamos National Laboratory, Los Alamos, New Mexico, 87545, United States of America.
Li-Wei HungLos Alamos National Laboratory, Los Alamos, New Mexico, 87545, United States of America.
James C SacchettiniDepartment of Biochemistry and Biophysics, Texas A & M University, College Station, Texas, 77843, United States of America.
Thomas C TerwilligerLos Alamos National Laboratory, Los Alamos, New Mexico, 87545, United States of America.
Tom AlberDepartment of Molecular and Cell Biology and California Institute for Quantitative Biosciences, University of California, Berkeley, California, 94720, United States of America.
Los Alamos National Laboratory · USUniversity of California, Berkeley · USQB3 · USTexas A&M University · US

Funding

Vulnerabilities in Mycobacterial Cell-Wall BiogenesisP01AI095208 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI ZHANG, JUNJIE · 2012 to 2022
$19.8M
NIAID NIH HHS AI095208NIAID NIH HHS P01 AI095208
6 · The paper itself

Abstract

Beta-lactam antibiotics target penicillin-binding proteins including several enzyme classes essential for bacterial cell-wall homeostasis. To better understand the functional and inhibitor-binding specificities of penicillin-binding proteins from the pathogen, Mycobacterium tuberculosis, we carried out structural and phylogenetic analysis of two predicted D,D-carboxypeptidases, Rv2911 and Rv3330. Optimization of Rv2911 for crystallization using directed evolution and the GFP folding reporter method yielded a soluble quadruple mutant. Structures of optimized Rv2911 bound to phenylmethylsulfonyl fluoride and Rv3330 bound to meropenem show that, in contrast to the nonspecific inhibitor, meropenem forms an extended interaction with the enzyme along a conserved surface. Phylogenetic analysis shows that Rv2911 and Rv3330 belong to different clades that emerged in Actinobacteria and are not represented in model organisms such as Escherichia coli and Bacillus subtilis. Clade-specific adaptations allow these enzymes to fulfill distinct physiological roles despite strict conservation of core catalytic residues. The characteristic differences include potential protein-protein interaction surfaces and specificity-determining residues surrounding the catalytic site. Overall, these structural insights lay the groundwork to develop improved beta-lactam therapeutics for tuberculosis.

Indexed as

Bacterial ProteinsCarboxypeptidasesCatalytic DomainCrystallography, X-RayDirected Molecular EvolutionEscherichia coli ProteinsMeropenemModels, MolecularMutationMycobacterium tuberculosisPenicillin-Binding ProteinsPhylogenyProtein ConformationThienamycinsBacterial ProteinsCarboxypeptidasesEscherichia coli ProteinsMeropenemPenicillin-Binding ProteinsThienamycins

Identifiers

PMID25551456
PMCPMC4281109
OpenAlexW2047331785

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.